Bogoslovni Vestnik.
Univerza v Ljubljani.
Vol. 80.
2020.
P. 463-475
A novel approach to safer glucocorticoid receptor–targeted anti-lymphoma therapy via REDD1 (regulated in development and DNA damage 1) inhibition
Authors
Lesovaya E.A.
1,
2
,
Savinkova A.V.1
,
Morozova O.V.1
,
Lylova E.S.1
,
Zhidkova E.M.1
,
Kirsanov K.I.
1,
3
,
Yakubovskaya M.G.
1
,
Kulikov E.P.2
,
Klopot A.4
,
Baida G.4
,
Budunova I.4
,
Gordon L.I.5
,
Readhead B.6,
7
,
Dudley J.T.6,
7
Journal
Publisher
AMER ASSOC CANCER RESEARCH
Number of issue
9
Language
English
Pages
1898-1908
Status
Published
Volume
19
Year
2020
Organizations
- 1 N.N. Blokhin NMRCO
- 2 I.P. Pavlov Ryazan State Medical University
- 3 RUDN University
- 4 Department of Dermatology|Northwestern University
- 5 Division of Hematology Oncology|Northwestern University
- 6 Department of Genetics and Genomic Sciences|Icahn School of Medicine at Mount Sinai
- 7 Icahn Institute of Genomics and Multiscale Biology|Icahn School of Medicine at Mount Sinai
Date of creation
06.07.2022
Date of change
06.07.2022
Share
Other records
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics).
Vol. 12563 LNCS.
2020.
P. 126-136